Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVGR NASDAQ:BBLG NASDAQ:GCTK NASDAQ:PTHL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$1.93$1.57M1.291.46 million shsN/ABBLGBone Biologics$2.60-1.4%$2.33$1.95▼$13.80$4.67M0.75845,625 shs23,850 shsGCTKGlucoTrack$7.25-0.2%$5.89$4.22▼$2,928.00$6.52M0.22792,173 shs19,137 shsPTHLPheton$0.73-0.9%$0.83$0.51▼$32.00$4.81MN/A901,770 shs48,268 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%0.00%-53.07%BBLGBone Biologics+5.60%+9.09%+14.29%-10.81%-74.42%GCTKGlucoTrack-1.89%+13.62%+48.47%+18.43%-99.72%PTHLPheton-6.36%-9.90%-27.66%-96.20%-87.26%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$1.93$1.57M1.291.46 million shsN/ABBLGBone Biologics$2.60-1.4%$2.33$1.95▼$13.80$4.67M0.75845,625 shs23,850 shsGCTKGlucoTrack$7.25-0.2%$5.89$4.22▼$2,928.00$6.52M0.22792,173 shs19,137 shsPTHLPheton$0.73-0.9%$0.83$0.51▼$32.00$4.81MN/A901,770 shs48,268 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%0.00%-53.07%BBLGBone Biologics+5.60%+9.09%+14.29%-10.81%-74.42%GCTKGlucoTrack-1.89%+13.62%+48.47%+18.43%-99.72%PTHLPheton-6.36%-9.90%-27.66%-96.20%-87.26%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVGRAvinger 0.00N/AN/AN/ABBLGBone Biologics 1.00SellN/AN/AGCTKGlucoTrack 1.00SellN/AN/APTHLPheton 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest AVGR, GCTK, PTHL, and BBLG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/27/2025BBLGBone BiologicsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E)9/27/2025GCTKGlucoTrackWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025PTHLPhetonWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVGRAvinger$7.65M0.21N/AN/A($4.53) per share-0.10BBLGBone BiologicsN/AN/AN/AN/A$8.39 per shareN/AGCTKGlucoTrackN/AN/AN/AN/A($983.43) per shareN/APTHLPheton$450K10.69N/AN/A$0.94 per share0.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVGRAvinger-$18.32M-$11.06N/AN/AN/AN/AN/AN/AN/ABBLGBone Biologics-$4.11MN/A0.00N/AN/AN/A-100.58%-93.31%11/13/2025 (Estimated)GCTKGlucoTrack-$22.60M-$56.60N/A∞N/AN/AN/A-352.05%N/APTHLPheton-$660KN/A0.00∞N/AN/AN/AN/AN/ALatest AVGR, GCTK, PTHL, and BBLG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025BBLGBone Biologics-$0.58-$1.33-$0.75-$1.33N/AN/A8/14/2025Q2 2025GCTKGlucoTrackN/A-$9.62N/A-$9.62N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVGRAvingerN/AN/AN/AN/AN/ABBLGBone BiologicsN/AN/AN/AN/AN/AGCTKGlucoTrackN/AN/AN/AN/AN/APTHLPhetonN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVGRAvingerN/AN/AN/ABBLGBone BiologicsN/A17.2517.25GCTKGlucoTrack0.033.273.27PTHLPhetonN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVGRAvinger18.30%BBLGBone Biologics34.30%GCTKGlucoTrack10.92%PTHLPhetonN/AInsider OwnershipCompanyInsider OwnershipAVGRAvinger42.80%BBLGBone Biologics6.10%GCTKGlucoTrack12.91%PTHLPhetonN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVGRAvinger703.31 million1.89 millionNot OptionableBBLGBone Biologics21.80 million1.66 millionNot OptionableGCTKGlucoTrack5900,000783,000Not OptionablePTHLPheton116.58 millionN/AN/AAVGR, GCTK, PTHL, and BBLG HeadlinesRecent News About These CompaniesPheton Holdings Enters Strategic Advisory Agreement with Comane InternationalSeptember 2, 2025 | tipranks.comPheton Holdings Acquires Stake in Geri-Safe to Boost Medical Device InnovationAugust 29, 2025 | tipranks.comPheton Holdings Acquires Majority Stake in iTonic CorporationAugust 29, 2025 | tipranks.comDeepfake of fund manager Anthony Bolton could savage your savings in 'pump and dump' shares scamAugust 18, 2025 | msn.comPenny stock selloffs fuel concerns over pump-and-dump scams - reportAugust 18, 2025 | msn.comPheton Holdings Addresses Market Volatility and RumorsAugust 6, 2025 | theglobeandmail.comPheton Holdings Ltd Addresses Market Volatility and Denies Acquisition RumorsAugust 1, 2025 | quiverquant.comQPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors | ...August 1, 2025 | gurufocus.comPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading RumorsAugust 1, 2025 | globenewswire.comPheton Holdings Ltd. Cl A (PTHL) Stock Price Today - WSJJuly 31, 2025 | wsj.comChinese Health Care Stock Pheton Holdings Collapses After Short Seller Warns Of Manipulation By 'Overseas Scammers'July 30, 2025 | benzinga.comPTHL: Trading Resumes for Pheton Holdings LtdJuly 29, 2025 | gurufocus.comPheton Holdings Ltd (PTHL) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comPTHL Pheton Holdings Ltd - Seeking AlphaJune 27, 2025 | seekingalpha.comPheton Holdings Ltd Announces Closing of Initial Public OfferingSeptember 6, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAVGR, GCTK, PTHL, and BBLG Company DescriptionsAvinger NASDAQ:AVGRAvinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.Bone Biologics NASDAQ:BBLG$2.60 -0.04 (-1.36%) As of 12:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.GlucoTrack NASDAQ:GCTK$7.24 -0.02 (-0.21%) As of 12:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.Pheton NASDAQ:PTHL$0.73 -0.01 (-0.94%) As of 12:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Insiders Buy Shares—Should Investors Follow Suit? TrumpRx Brings Pfizer Into the Green—Is It a Buy? Behind D-Wave's Massive Week (And Why Rivals Also Popped) Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal 2 Defense Stocks Riding 2025’s Massive Momentum Wave Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? Best Stocks Under $15? 3 Low-Priced Picks With Upside Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
